Prognostic Role of Metabolic Exercise Testing in Heart Failure

Area of Science:

• Cardiology
• Exercise Physiology

Background:

• Heart failure (HF) is a heterogeneous syndrome requiring accurate risk stratification.
• Current prognostic markers, like left ventricular ejection fraction (LVEF), have limitations in reflecting functional capacity and prognosis.
• LVEF alone provides an incomplete characterization of HF, potentially misguiding clinical decisions.

Purpose of the Study:

• To review the role of metabolic exercise testing (MET) as a complementary diagnostic and prognostic tool in heart failure.
• To highlight MET's ability to provide a comprehensive, multisystem evaluation of exercise response.

Main Methods:

• Review of existing literature on metabolic exercise testing in heart failure.
• Explanation of MET's capacity to assess the integrated physiological response to exercise.
• Description of how MET identifies contributors to exercise intolerance.

Main Results:

• MET provides a comprehensive evaluation of neurological, respiratory, circulatory, and musculoskeletal responses to exercise.
• Aerobic exercise capacity, measured by oxygen consumption, correlates with life expectancy and prognosis.
• MET offers an accurate, objective, and reproducible assessment of circulatory sufficiency and reserve in heart failure patients.

Conclusions:

• Metabolic exercise testing is a valuable prognostic modality across the heart failure spectrum.
• MET complements LVEF by providing a more complete understanding of HF severity and patient prognosis.
• This testing modality aids in guiding management decisions, especially in advanced heart failure.